Research funder · United States
Melanoma Research Alliance
Nonprofit organization in Washington D.C., United States
- Grants since 2016
- 400
- Awarded, last 5 years (where amounts are published)
- 72.1M
- Funded works, last 5 years
- 1 190
- Funded works, all time
- 2 826
Grants
2017–2019 · award
Dissecting the significance of pigment heterogeneity in cutaneous melanoma
Mark Shackleton
2017–2020 · award
Granzyme B imaging to predict efficacy of immunotherapy in melanoma
Umar Mahmood
2017–2020 · award
Melanocyte stem cells and their progression to malignancy and metastasis
Elaine Fuchs
2017–2020 · award
Biomarker-based application of anti-apoptotic inhibitors in melanoma
Rizwan Haq
2017–2020 · award
Immune Evasion Mechanisms in MAPKi and Anti-PD-1 Treated Melanoma
Willy Hugo
2017–2020 · award
Molecular Mechanism of UV-induced Mutagenesis in Melanoma
Chengyu Liang
2017–2020 · award
A human T cell genetic screen for melanoma immunotherapy
Neville Sanjana
2017–2019 · award
MDSC Recruitment as an Adaptive Resistance Mechanism to PD-1 Ab Therapy
Brent Hanks
2017–2021 · award
The miR-29 circuit in melanoma initiation and progression
Florian Karreth
2017–2019 · award
Targeting Foxp3 and NMD blockade in melanoma to unleash tumor immunity.
Fernando Pastor
2017–2021 · award
Advancing SBI-756, A Translation Initiation Inhibitor, for Melanoma Therapy
Zeev Ronai
2017–2020 · award
Single cell analysis and perturbation of the tumor-immune ecosystem
Ido Amit
2017–2020 · award
Adipocytes in the melanoma microenvironment
Richard White
2017–2021 · award
Single-cell biomarkers for engineering T-cell function and metabolism
Navin Varadarajan
2017–2021 · award
Molecular epidemiology on gender difference in early onset melanoma
Feng Liu-Smith
2017–2021 · award
Overcome Resistance to PD1 Blockade by Adding Oncolytic Virus TVEC
Siwen Hu-Lieskovan
2017–2020 · award
Downregulating CTLA4 on effector T cells to improve anti-CTLA4 efficacy
Erica Stone
2016–2019 · award
Identification of novel regulators of melanoma brain metastasis
Carmit Levy
2016–2021 · award
Inhibition of BET Bromodomain Proteins in Uveal Melanoma
Gary Schwartz
2016–2019 · award
Immunometabolic editing facilitates immune evasion in melanomas
Ping-Chih Ho
2016–2019 · award
Lymphatic Vessels and T cell-Inflammation in Melanoma
Amanda Lund
2016–2020 · award
Inherited variation and irAEs and outcome with Nivo and Ipi/Nivo
Katherine Nathanson
2016–2020 · award
Bispecific antibodies and T cell activating proteins against melanoma
Sebastian Kobold
2016–2020 · award
Targeted Therapy for Metastatic Melanoma: A Phase I Dose-Expansion Cohort
Paul Hergenrother
2016–2019 · award
Enhancing immune therapy for brain metastases with focused ultrasound
Timothy Bullock
2016–2019 · award
Identifying somatic and microbial neo-antigens associated with melanoma res
Yardena Samuels
2016–2019 · award
Small-molecule targeting of the lineage-specific melanoma oncogene MITF
David Fisher
2016–2020 · award
Determinants of Response or Resistance to PD-1/PD-L1 Targeted Therapy
Roger Lo
2016–2019 · award
Imaging and targeting dormant and pro-metastatic melanoma lesions in vivo
Maria Soengas
2016–2019 · award
Mechanism-based strategies to forestall resistance in BRAF-mutant melanoma
Poulikos Poulikakos
2016–2021 · award
Targeting mitochondrial metabolism in melanoma therapy
David Lombard
2016–2019 · award
Targeted Alpha Particle Therapy for Uveal Melanoma
David Morse
2016–2019 · award
Developing rational therapeutic approaches for acral melanoma
Boris Bastian
2016–2019 · award
Metabolic Regulation of the Tumor Immune Response by the Microenvironment
Marcus Bosenberg
2016–2019 · award
Genome scale identification of genes regulating melanoma metastasis
Sidi Chen
2016–2019 · award
Identification of therapeutic strategies to target NF1 mutant melanomas
Ian Watson
2015–2021 · award
Humanized melanoma mouse models for translational assessment of neoantigen-based vaccines
Nina Bhardwaj
2015–2020 · award
Radiation and immune checkpoint blockade from mechanism to patients
Robert Vonderheide
2015–2020 · award
Evaluation of Intermittent MEK Inhibition in Uveal Melanoma
Richard Carvajal
2013–2020 · award
Exploring the role of CDK4 and CDK6 in melanoma maintenance
Martin Mcmahon